Why Canaloplasty Is Emerging as a Strategic Advantage in Modern Glaucoma Care

Canaloplasty is gaining renewed attention as glaucoma care shifts toward procedures that lower intraocular pressure while preserving the eye’s natural anatomy. Unlike more invasive filtering surgeries, canaloplasty targets the conventional outflow pathway by dilating Schlemm’s canal and improving aqueous drainage. For surgeons and healthcare leaders, this matters because the conversation is no longer only about pressure reduction, but also about safety, recovery, and long-term patient experience.

The growing interest in canaloplasty reflects a broader market and clinical trend: demand for minimally invasive glaucoma solutions that fit earlier intervention strategies. When combined with cataract surgery or positioned for selected open-angle glaucoma patients, canaloplasty can offer meaningful pressure control with a favorable safety profile and reduced dependence on postoperative management compared with traditional bleb-forming approaches. This makes it especially relevant in practices focused on efficiency, patient satisfaction, and sustainable care pathways.

For decision-makers, canaloplasty represents more than a surgical technique; it signals where glaucoma management is heading. The future belongs to interventions that balance efficacy with predictability and support value-based care. As innovation continues across devices and procedural refinements, canaloplasty stands out as a strong example of how ophthalmology is moving toward tissue-sparing, workflow-conscious, and patient-centered treatment models.